GLP-1 analogues as adjunctive therapy for type 1 diabetes: systematic review and meta-analysis (24 RCTs, N=3,377)
has received honoraria, teaching, and research sponsorship/grants from Abbott, AstraZeneca, Boehringer Ingelheim, Cellnovo, Eli Lilly, Merck Sharp & Dohme, Novo Nordisk, and Sanofi-aventis, Cardiff University, Doctors.net, Elsevier, Onmedica, Omnia-Med, Medscape, All-Wales Medicines Strategy Group, National Institute for Health and Care Excellence (NICE) UK, and Glycosmedia
Ozempic Butt, characterized by sagging skin on the butt, is gaining traction as a reported side effect of the weight loss drug semaglutide, better known by the popular brand names Ozempic and Wegovy
Does Omzo GLP-1 require a video appointment or can it be done asynchronously
Oz's insightful discussion on Semaglutide in this video
The effect of berberine supplementation on obesity parameters, inflammation and liver function enzymes: A systematic review and meta-analysis of randomized controlled trials